SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.930
+0.040 (1.03%)
Mar 4, 2026, 4:00 PM EST - Market closed
SAB Biotherapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.